title: Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.
abstract: The underlying molecular mechanisms that cause immune cells, mediators of our defense system, to promote tumor invasion and angiogenesis remain incompletely understood. Constitutively activated Stat3 in tumor cells has been shown to promote tumor invasion and angiogenesis. Therefore, we sought to determine whether Stat3 activation in tumor-associated inflammatory cells has a similar function. We found that Stat3 signaling mediates multidirectional crosstalk among tumor cells, myeloid cells in the tumor stroma, and ECs that contributes to tumor angiogenesis in mice. Myeloid-derived suppressor cells and macrophages isolated from mouse tumors displayed activated Stat3 and induced angiogenesis in an in vitro tube formation assay via Stat3 induction of angiogenic factors, including VEGF and bFGF. Stat3-regulated factors produced by both tumor cells and tumor-derived myeloid cells also induced constitutive activation of Stat3 in tumor endothelium, and inhibiting Stat3 in ECs substantially reduced in vitro tumor factor-induced endothelial migration and tube formation. In vivo assays demonstrated the requirement for Stat3 signaling in tumor-associated myeloid cells for tumor angiogenesis. Our results indicate that, by virtue of the ability of Stat3 in tumor cells and tumor-derived myeloid cells to upregulate expression of factors that activate Stat3 in ECs, Stat3 mediates multidirectional crosstalk among tumor cells, tumor-associated myeloid cells, and ECs that contributes to tumor angiogenesis.
authors.affiliation: Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA.
authors.forename: Maciej
authors.initials: M
authors.lastname: Kujawski
authors.forename: Marcin
authors.initials: M
authors.lastname: Kortylewski
authors.forename: Heehyoung
authors.initials: H
authors.lastname: Lee
authors.forename: Andreas
authors.initials: A
authors.lastname: Herrmann
authors.forename: Heidi
authors.initials: H
authors.lastname: Kay
authors.forename: Hua
authors.initials: H
authors.lastname: Yu
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D003094:Collagen / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D016018:Least-Squares Analysis; D008546:Melanoma, Experimental / Q000098:blood supply / Q000503:physiopathology; D051379:Mice; D008810:Mice, Inbred C57BL; D022423:Myeloid Cells / Q000378:metabolism*; D009369:Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D050796:STAT3 Transcription Factor / Q000378:metabolism*
chemical_list: D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D003094:Collagen
references.citation: Cancer Res. 2007 Oct 15;67(20):10019-26
references.pmid: 17942936
references.citation: J Clin Invest. 2007 May;117(5):1155-66
references.pmid: 17476345
references.citation: Cancer Cell. 2008 Jan;13(1):23-35
references.pmid: 18167337
references.citation: Cell Signal. 2007 Dec;19(12):2487-97
references.pmid: 17826033
references.citation: Science. 1995 Jul 7;269(5220):81-3
references.pmid: 7541555
references.citation: Crit Rev Oncol Hematol. 2008 Apr;66(1):1-9
references.pmid: 17913510
references.citation: J Exp Med. 2006 Jul 10;203(7):1651-6
references.pmid: 16801397
references.citation: Cancer Cell. 2004 Oct;6(4):409-21
references.pmid: 15488763
references.citation: Cancer Res. 2005 Apr 15;65(8):3200-8
references.pmid: 15833851
references.citation: Cancer Res. 2004 Oct 1;64(19):7099-109
references.pmid: 15466206
references.citation: Cancer Res. 2007 Dec 1;67(23):11438-46
references.pmid: 18056472
references.citation: J Clin Invest. 2005 Nov;115(11):2979-91
references.pmid: 16239969
references.citation: Cancer Cell. 2005 Jul;8(1):13-23
references.pmid: 16023595
references.citation: Cancer Res. 1999 Oct 15;59(20):5059-63
references.pmid: 10537273
references.citation: Blood. 2006 Dec 1;108(12):3682-90
references.pmid: 16888100
references.citation: Nat Immunol. 2002 Nov;3(11):991-8
references.pmid: 12407406
references.citation: J Immunol. 2006 Jan 1;176(1):284-90
references.pmid: 16365420
references.citation: FASEB J. 2003 Aug;17(11):1562-4
references.pmid: 12824281
references.citation: Oncogene. 1999 Jun 24;18(25):3742-53
references.pmid: 10391682
references.citation: Annu Rev Immunol. 2003;21:807-39
references.pmid: 12615893
references.citation: Cell. 2006 Jan 27;124(2):263-6
references.pmid: 16439202
references.citation: Cancer Res. 2007 Mar 15;67(6):2649-56
references.pmid: 17363585
references.citation: J Exp Med. 2005 Oct 3;202(7):919-29
references.pmid: 16186184
references.citation: Oncogene. 2002 Mar 27;21(13):2000-8
references.pmid: 11960372
references.citation: Cancer Res. 2003 Jun 1;63(11):2971-6
references.pmid: 12782605
references.citation: Nat Rev Immunol. 2007 Jan;7(1):41-51
references.pmid: 17186030
references.citation: J Biol Chem. 2003 Oct 10;278(41):40026-31
references.pmid: 12874294
references.citation: J Clin Invest. 2007 Dec;117(12):3846-56
references.pmid: 18060032
references.citation: Nat Rev Cancer. 2004 Jul;4(7):540-50
references.pmid: 15229479
references.citation: J Exp Med. 2006 Apr 17;203(4):1021-31
references.pmid: 16606674
references.citation: J Exp Med. 2005 Nov 21;202(10):1399-410
references.pmid: 16287709
references.citation: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10602-7
references.pmid: 15249664
references.citation: J Exp Med. 2005 Mar 7;201(5):779-91
references.pmid: 15753211
references.citation: Nat Med. 2004 Sep;10(9):942-9
references.pmid: 15322536
references.citation: Immunity. 2002 Jul;17(1):63-72
references.pmid: 12150892
references.citation: Nat Med. 2005 Dec;11(12):1314-21
references.pmid: 16288283
references.citation: Cancer Res. 2006 Mar 15;66(6):3188-96
references.pmid: 16540670
references.citation: Blood. 2003 Sep 15;102(6):2138-45
references.pmid: 12750171
references.citation: J Immunol. 2005 Apr 1;174(7):3925-31
references.pmid: 15778348
references.citation: Nat Rev Cancer. 2004 Feb;4(2):97-105
references.pmid: 14964307
references.citation: Adv Exp Med Biol. 2007;604:67-86
references.pmid: 17695721
references.citation: Blood. 2008 Jan 1;111(1):219-28
references.pmid: 17885078
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2645-50
references.pmid: 12598651
references.citation: Nat Rev Cancer. 2004 Jan;4(1):71-8
references.pmid: 14708027
references.citation: Oncogene. 2003 Jan 23;22(3):319-29
references.pmid: 12545153
references.citation: Nat Med. 2004 Jan;10(1):48-54
references.pmid: 14702634
references.citation: Nat Rev Immunol. 2005 Jul;5(7):521-31
references.pmid: 15999093
references.citation: Nat Clin Pract Oncol. 2005 Jun;2(6):315-24
references.pmid: 16264989